Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Vir Biotechnology Q1 2026 Earnings Call - Astellas Partnership Closes, HDV Data Shows 88% Viral Clearance
Vir Biotechnology closed its landmark $1.7 billion global collaboration with Astellas for VIR-5500, a PRO-XTEN dual-masked PSMA-targeted T-cell engager, bringing an initial $315 million in proceeds an...
- Astellas collaboration for VIR-5500 officially closed on April 15, 2026, delivering an immediate $315 million in cash proceeds and shifting global development costs to a 40/60 split in Vir's favor.
- VIR-5500 phase I data demonstrated a favorable safety profile with no dose-limiting toxicities and grade 1 cytokine release syndrome only at doses of 3,000 mcg/kg and above, supporting outpatient administration potential.
- Deep PSA and RECIST responses were observed in heavily pretreated mCRPC patients, including those with liver metastasis and prior radioligand therapy failure, with durability extending up to 12 months in select cases.
- +7 more takeaways
NeuroOne Medical Technologies Corporation Q2 Fiscal 2026 Earnings Call - OneRF Revenue Surges 72% as Management Pivots to International Expansion and New Product Rollouts
NeuroOne’s second quarter fiscal 2026 results paint a picture of a company in transition, balancing rapid growth in its core brain ablation business with the slow burn of developing new therapeutic pl...
- Product revenue grew 72% year over year to $2.4 million in Q2 fiscal 2026, driven by strong sales of the OneRF brain ablation system.
- The company lost $3 million in license revenue from its Zimmer Biomet partnership, a significant drop from the prior year that highlights the shift to direct product sales.
- Cash and cash equivalents declined sharply to $2.8 million as of March 31, 2026, down from $6.6 million six months earlier, raising questions about the timeline for a potential capital raise.
- +7 more takeaways
Achieve Life Sciences Q1 2026 Earnings Call - Cytisinicline NDA Resubmission Pushed to Q4 2026 Following Manufacturing CRL, $180M Financing Secured
Achieve Life Sciences navigated a pivotal quarter marked by a leadership transition and a manufacturing setback that delays its NDA resubmission for cytisinicline, a potential first-in-class smoking c...
- Achieve Life Sciences closed a transformative $180 million private placement, plus up to $174 million from milestone-based warrants exercisable around FDA approval, significantly strengthening its balance sheet for commercialization.
- CEO Dr. Andrew Goldberg emphasized a strategy of independent commercialization with a dedicated field force, leveraging new hires from Verona Pharma’s successful Ohtuvayre launch to drive execution.
- The company expects to receive a Complete Response Letter (CRL) from the FDA by its June 20, 2026 PDUFA date, primarily due to CGMP observations at a third-party manufacturer unrelated to the drug product itself.
- +7 more takeaways
Eco Wave Power Q1 2026 Earnings Call - Wave Energy Positioned for AI Infrastructure Boom
Eco Wave Power reported a tighter operating loss of $682,000 in Q1 2026, down from $765,000 a year prior, driven by disciplined cost cuts across R&D, sales, and administration. The company holds $5.3 ...
- Operating expenses fell 11% year-over-year to $682,000, with R&D dropping to $140,000 from $181,000 and G&A down to $499,000 from $539,000.
- Operating loss improved to $682,000 from $765,000 in Q1 2025, though net loss widened to $695,000 due to foreign exchange fluctuations.
- The company maintains $5.3 million in total liquidity as of March 31, 2026, ensuring runway for ongoing operations and project development.
- +7 more takeaways
WM Technology Q1 2026 Earnings Call - Strategic Delisting and Cannabis Rescheduling Unlocks Next Phase
WM Technology reported Q1 2026 revenue of $43.6 million, down 2% year-over-year but in line with expectations. The company navigated a difficult operating environment marked by price compression, elev...
- Revenue for Q1 2026 was $43.6 million, down 2% year-over-year but up 1% sequentially, aligning with management expectations.
- Average monthly paying clients declined 4% year-over-year to approximately 4,983, primarily due to churn in mature markets like California, Michigan, and Colorado.
- Client churn was driven by financial stress, price compression, and non-payment issues among operators in saturated markets.
- +7 more takeaways
Novanta Inc Q1 2026 Earnings Call - Bookings Surge 37% as AI and Medical Tech Drive Broad-Based Momentum
Novanta delivered a sharp turn in momentum in Q1 2026, with organic revenue growth accelerating to 3% and bookings jumping 37% year-over-year. The company is riding a broad-based wave of demand across...
- Bookings surged 37% year-over-year with a book-to-bill ratio of 1.10, signaling robust demand across all business units and setting the stage for accelerated revenue growth.
- Organic revenue growth accelerated to 3% in Q1 2026, with management raising full-year guidance to expect organic growth of up to 6%, reflecting a clear inflection in momentum.
- New product revenue jumped 50% year-over-year, and design wins were up nearly 30%, validating the company’s innovation-driven strategy and sticky OEM partnerships.
- +7 more takeaways
Ambiq Micro Q1 2026 Earnings Call - Edge AI Demand Outpaces Supply, Diversification Gains Traction
Ambiq Micro delivered a sharp start to 2026, with Q1 net sales of $25.1 million beating guidance and rising 59% year-over-year. The growth was driven by broad-based demand for edge AI across wearables...
- Q1 2026 net sales reached $25.1 million, up 59.3% year-over-year and beating guidance, driven by strong demand for edge AI across wearables and new markets.
- Over 80% of Ambiq’s units now run AI algorithms, with demand accelerating across form factors including watches, rings, and smart eyewear.
- The company successfully diversified its customer base, reducing the revenue share of its top three customers from 86% in Q1 2025 to 71% in Q1 2026.
- +7 more takeaways
Millicom Q1 2026 Earnings Call - Coltel Integration and Chile Turnaround Drive Record Cash Flow
Millicom delivered a robust Q1 2026, driven by the consolidation of Coltel in Colombia and the successful application of its turnaround playbook in Ecuador and Uruguay. Reported service revenue surged...
- Reported service revenue jumped 45% YoY to $1.9 billion, driven by the consolidation of Coltel; organic service revenue growth remained a healthy 4.9%.
- Adjusted EBITDA reached $857 million with a 43.2% margin; excluding Coltel, the margin expanded to 47.9%, highlighting underlying operational strength.
- Equity free cash flow hit a record Q1 of $225 million, up 66% year-over-year, supported by disciplined cost management and FX tailwinds.
- +7 more takeaways
Silvercrest Asset Management Q1 2026 Earnings Call - Heavy Investment Costs Weigh on Margins Amid Global Expansion
Silvercrest Asset Management entered its 25th year with a clear strategic pivot toward global expansion, but the Q1 2026 financials reflect the heavy price tag of that ambition. Discretionary AUM fell...
- Discretionary AUM declined 3.7% sequentially to $23.1 billion, driven by net institutional outflows, though year-over-year discretionary AUM grew nearly 2%.
- Total AUM increased 1.1% year-over-year to $35.7 billion, with management noting a future accounting change will lower non-discretionary AUM reporting without impacting revenue.
- Revenue remained flat at $31.4 million year-over-year, while expenses rose 13.5% to $22.4 million, primarily due to increased compensation and administrative costs.
- +9 more takeaways
NET Power Q1 2026 Earnings Call - Commercial Offtake Process Gating Capital Commitment for Permian Phase I
NET Power is pivoting hard from engineering to commercialization, making the offtake process for Project Permian Phase I the single most critical milestone. The company is holding back on major capita...
- NET Power is prioritizing commercial offtake agreements as the gating condition for project financing and capital deployment for Project Permian Phase I.
- The company has $319 million in cash and no debt, providing ample runway to reach final investment decision while maintaining a low quarterly burn rate of $8 million to $9 million.
- Project Permian Phase I targets 80 MW net output with over 90% CO2 capture, sited in West Texas with plans to scale to 800 MW on the same acreage.
- +7 more takeaways